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A mathematical technique known as deconvolutional analysis was used to provide a critical and 
previously missing element in the computations required to quantitate hepatic function scintigraphi- 
tally. This computer-assisted technique allowed for the determination of the time required, in minutes, 
of a labeled bilirubin analog (ggmTc-disofenin) to enter the liver via blood and exit via bile. This interval 
was referred to as the mean transit time (MTT). The critical process provided for by deconvolution is 
the mathematical simulation of a bolus injection of tracer directly into the afferent blood supply of the 
liver. The raw data required for this simulation are obtained from the intravenous injection of labeled 
disofenin, a member of the HIDA family of radiopharmaceuticals. In this study, we perform experi- 
ments which document that the simulation process itself is accurate. We then calculate the MTT under 
a variety of experimental conditions involving progressive hepatic ischemia/reperfusion injury and 
correlate these results with the results of simultaneously performed BSP determinations and hepatic 
histology. The experimental group with the most pronounced histologic findings (necrosis, vacuoliza- 
tion, disorganization of hepatic cords) also have the most prolonged MTT and BSP half-life. However, 
both quantitative imaging and BSP testing are able to identify milder degrees of hepatic ischemic injury 
not reflected in the histologic evaluation. Quantitative imaging with deconvolutional analysis is a 
technique easily adaptable to the standard nuclear medicine minicomputer. It provides rapid results 
and appears to be a sensitive monitor of hepatic functional disturbances resulting from &hernia and 
reperfusion. 0 1987 Academic Press, Inc. 
INTRODUCTION 
There is currently no reliable method to 
assess acute changes in liver function. One 
must rely on clinical findings or measure 
changes in the level of substances metabo- 
lized by the liver, a process which involves a 
considerable time delay between cause and 
effect. In this report we describe a scintigra- 
phic technique coupled with a computer-as- 
sisted mathematical interpretation which re- 
liably assesses hepatic function on an acute 
basis. Because this test is sensitive, minimally 
invasive, and very rapid, it has great poten- 
tial for clinical application. In particular, this 
’ To whom correspondence and reprint requests 
should be addressed: Department of Surgery, University 
of Michigan Medical Center, 2926D Taubman Center, 
Box 0331, Ann Arbor, MI 48109. 
technique lends itself to use in the context of 
liver transplantation, where rapid changes in 
the function of the newly transplanted, or 
potentially rejecting, liver are of paramount 
importance. 
The scintigraphic measurement of hepatic 
function requires the following: a test sub- 
stance must be handled exclusively by the 
liver; it must be secreted into the bile without 
significant “leak” back into the blood 
stream; and it must be presented to the liver 
in the form of a single, short intravascular 
bolus. If these conditions are met, it is a 
straightforward matter to measure the total 
uptake of the test substance by the liver and 
to quantitate subsequent excretion. The in- 
troduction of the HIDA family of scinti- 
graphic reagents in 1975 [ 1, 21 provided 
drugs capable of satisfying the first two crite- 
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ria [3, 41 but it has not been possible in the 
clinical setting to administer the test sub- 
stance in question directly into the dual 
blood supply of the liver, the portal vein, and 
hepatic artery. The intravenous injection of 
test substance is not an adequate substitute 
since the liver receives only a fraction of the 
total cardiac output, and substantial 
amounts of the injected material would by- 
pass the liver on the first pass, to be “recircu- 
lated” through the liver subsequently. Be- 
cause of recirculation, the liver is presented 
with a continually changing concentration of 
tracer. This, coupled with simultaneous ex- 
traction of tracer from blood by the liver, 
makes it impossible to define a baseline ini- 
tial level of maximum uptake and to pre- 
cisely measure the subsequent rate of excre- 
tion. 
In this paper we use a technique called de- 
convolution, which analyzes data obtained 
from the intravenous injection of 99”Tc-dis- 
ofenin and mathematically constructs a sim- 
ulated bolus injection of tracer into the blood 
supply of the liver. In this simulated injec- 
tion, tracer is presented to the liver initially, 
but the effects of recirculation are corrected 
so that measurement of the time required for 
transit of tracer through and out of the liver 
is easily calculated. 
MATERIAL AND METHODS 
99”Tc-Disofenin Scan with Deconvolution 
In order to quantitatively measure hepato- 
cyte function in the acute setting, we per- 
formed scintigraphic imaging with 99mT~- 
disofenin, a member of the HIDA family of 
tracers. Imaging was initiated within 30 min 
of completion of the surgical procedure. 
Each animal was imaged using a wide field- 
of-view gamma camera positioned ventrally 
(General Electric 400 AT camera with gen- 
eral-purpose low-energy parallel hole colli- 
mator) so as to include both the heart and 
liver in the field. Each animal was then in- 
jected intravenously with 5 mCi 99”Tcdiso- 
fenin and continuous 1 -min scintigraphic 
images were acquired for 32 min. These 
images were stored directly on a commercial 
nuclear medicine minicomputer (General 
Electric Star minicomputer). 
After data acquisition, computerized re- 
gions-of-interest of the heart and liver were 
drawn on the images. Using these, we gener- 
ated plots of the changing amount of radio- 
activity in the heart and liver over time 
(time-activity curves). Since there is no car- 
diac uptake of the tracer, the plot of radioac- 
tivity in the heart is analogous to a plot of the 
changing blood concentration of tracer over 
time. To correct the liver time-activity curve 
for the effects of continuing systemic recir- 
culation of tracer and the constantly chang- 
ing blood concentration of tracer, the com- 
puter was utilized to perform deconvolution 
of the liver curves. This was done by em- 
ploying the blood (heart) curve as a represen- 
tative input function using a computer pro- 
gram previously developed at this institution 
[5]. This method has been validated by com- 
puter simulation as well as in vivo models [6] 
and has proven useful in differentiating in- 
trahepatic from extrahepatic jaundice [7]. 
This procedure results in a liver time-activ- 
ity curve which has been “corrected” for the 
effects of systemic recirculation of tracer. 
The hepatic mean transit time (MTT) of 
tracer was then analyzed by integrating the 
area under this curve and dividing by the 
maximum height of the curve. 
The initial points of the “corrected” or de- 
convolved hepatic time-activity curve repre- 
sent the total tracer activity presented to the 
liver. Later points in the curve represent the 
relative amount of the initial tracer adminis- 
tered that is retained and excreted by the 
liver. 
Direct Administration of 99mTc-Disofenin 
into the Agerent Blood Supply of the Liver 
To validate these measurements, we com- 
pared the liver function of a normal pig liver 
assessed using the intravenous administra- 
tion of 99”Tc-disofenin and deconvolution 
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(indirect method) to results obtained when 
the same agent was simultaneously adminis- 
tered directly into both the hepatic artery 
and the portal vein (direct method). For the 
latter technique, pigs were operated upon 
through a midline incision and the gastro- 
duodenal artery and gastroduodenal vein 
were cannulated with a small piece of poly- 
ethylene tubing connected to a syringe and 
three-way stopcock. The right gastric artery 
and any smaller branches leading to the 
stomach were ligated and divided so that the 
entire amount of injected radionuclide 
reached the liver. Five millicuries of 99mTc- 
disofenin for injection was then divided so 
that two-thirds was administered via the por- 
tal vein and one-third was administered via 
the hepatic artery. This somewhat arbitrary 
division was based on the normal 2: 1 ratio of 
portal vein to hepatic arterial blood flow ob- 
served in humans [8]. Computer image ac- 
quisition was started and both doses were in- 
jected simultaneously into the portal vein 
and hepatic artery and were followed with a 
~-CC flush of heparinized normal saline. After 
data acquisition, the indirect assay was per- 
formed in the same animal so that each 
served as its own control. 
BSP Retention 
The clearance rate of bromosulfophthalein 
(BSP) is a commonly used indicator of liver 
function in domestic animals [9]. The pres- 
ence of liver dysfunction increases the con- 
centration of BSP at a specified time and 
thus prolongs plasma half-life. 
Sterile disodium phenoltetrabromophtha- 
lein disulfanate (5 mg/kg) was administered 
intravenously I hr following reperfusion of 
the liver with blood. Blood samples were col- 
lected at 5 and 30 min. A spectrophotomet- 
ric determination at 565 mu was performed 
following the addition of 1.0 N NaOH and 
distilled water to each plasma sample. The 
concentration of BSP was then derived from 
a previously constructed standard curve. 
Half-lives were calculated using the following 
formula: 
0.693 
T1’2 = 2.303((log Ci - log C2)/(T2 - TJ) 
T, = 5 min 
T2 = 30 min 
C, = [BSP] at 5 min 
C2 = [BSP] at 30 min 
Transplantation Technique 
The technique for porcine allograft liver 
transplantation has been described elsewhere 
[ 10, 111. Briefly, donor livers were harvested 
after in situ perfusion of the portal vein with 
cold (4°C) Eurocollins solution. While ex 
vivo, a total of 1500 ml of cold perfusate was 
administered through the portal vein and 
hepatic artery. The donor livers were sub- 
jected to an average cold ischemic time of 
1 hr. 
Recipient hepatectomy was performed fol- 
lowing placement of a passive veno-venous 
bypass circuit. Blood from both the portal 
vein and the infrahepatic vena cava was 
shunted via a Y-connector to the right exter- 
nal jugular vein. The suprahepatic vena 
caval anastomosis was performed first, fol- 
lowed by the portal vein. Prior to completion 
of the latter anastomosis, 1000 cc of warm 
saline was perfused through the portal vein. 
Both this maneuver and the administration 
of intravenous calcium chloride were used to 
protect against hyperkalemia which occurs 
immediately upon revascularization (re- 
moval of the portal vein and suprahepatic 
clamps) [ 121. The average warm ischemic 
time (out of ice) was 35 min. The infrahe- 
patic vena cava, hepatic artery (end to side to 
recipient common hepatic), and bile duct 
anastomoses were then completed in se- 
quence. 
Ischemic Technique 
In order to further study the 99mTc-diso- 
fenin scan, an operative technique was de- 
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vised to subject the liver to warm absolute 
ischemia. Initial hepatic dissection and 
placement of a veno-venous bypass circuit 
were carried out, similar to the transplant 
operation. However, instead of removing the 
liver, Satinsky clamps were placed across the 
remainder of the portal triad and around the 
suprahepatic vena cava, thus rendering the 
liver totally ischemic. After the prescribed 
ischemic length, the clamps and shunt were 
removed, and the portal vein and infrahe- 
patic vena caval venotomies were closed with 
a running 5-O Tevdek. One hour following 
revascularization, BSP measurements were 
performed and the pigs were then scanned. 
Histologic Evaluation 
Open liver biopsies taken from the free 
edge of the left lobe were routinely obtained 
1 hr following revascularization and pro- 
cessed for histologic evaluation. Light micro- 
scopic evaluation was performed by one of 
us in blinded fashion. Slides were evaluated 
for various histologic changes, with necrosis, 
vacuolar changes, and disorganization of he- 
patic cords being the most discriminatory 
characteristics. 
RESULTS 
Figure 1 demonstrates the scintigraphic 
appearance of the liver after the direct (A) 
and indirect (B) injections of 99”Tc-diso- 
fenin. After direct injection, only the liver is 
demonstrated and neither lung nor heart ac- 
tivity is observed, owing to the very high ex- 
traction efficiency of the liver for disofenin. 
In contrast, after an iv injection of 99”‘Tc-dis- 
ofenin both heart and liver are readily ob- 
served (B). Figure 2 shows the time-activity 
curves generated from the indirect and direct 
injections of 99mTc-disofenin for three nor- 
mal animals. The calculated correlation co- 
efficient was 0.95. The calculated mean 
transit time MTT) for each technique in each 
animal is shown in Table 1. A paired t test 
comparing MTT determinations after direct 
FIG. 1. Scintigraphic appearance after direct injection of 99mTcdisofenin into portal vein and hepatic 
artery (A) and after intravenous injection (B). In contrast to the intravenous injection, after direct injection 
no tracer is identified in the area of the heart. The arrow in (A) indicates the site of injection of tracer into 
the portal vein and hepatic artery. The arrow in (B) indicates tracer in the chambers of the heart. 
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FIG. 2. Hepatic time-activity curves for the liver after 
intravenous injection of 99mTc-disofenin or direct injec- 
tion of 99mTc-disofenin into the portal vein and hepatic 
artery. The correlation coefficient for these curves was 
0.95. 
and indirect measurements did not reveal a 
statistically significant difference. 
One animal suffered an unexplained car- 
diac arrest during placement of the gastro- 
duodenal artery and vein catheters and was 
asystolic for several minutes before resuscita- 
tion was begun. After successful resuscita- 
tion, which included open cardiac massage 
and the administration of epinephrine, the 
experiment proceeded, although the liver ap- 
peared to be distinctly abnormal (mottled) in 
appearance thereafter. However, the curves 
again appeared similar and the calculated 
MTTs were also similar although prolonged 
compared to the three normal animals 
(Table 1). 
Sensitivity of Quantitative Hepatic 
Scintigraphy and BSP Determinations to 
Varying Degrees of Ischemic Injury and 
Correlation with Hepatic Histology 
We considered it important to document 
the degree to which quantitative scintigraphy 
using the deconvolution technique could dis- 
tinguish between varying degrees of hepatic 
ischemic injury. Pigs were subjected to 0.5 or 
1 .O hr of warm hepatic ischemia. In addition 
some pigs underwent orthotopic allotrans- 
plantation, which involved a 1-hr period of 
cold ischemia (Collins preservation solution 
and ice storage) and an additional 35-min 
period of warm ischemia. After a 1 -hr period 
of postischemia reperfusion for all experi- 
mental groups, BSP determinations were 
done, quantitative imaging was accom- 
plished, and biopsies were taken. 
The calculated half-life for BSP following 
injection was incrementally prolonged with 
increasing amounts of ischemic injury (Fig. 
3) ranging from a T,,2 of 43 min in the recipi- 
ents of transplants stored in ice for 1 hr. Like- 
wise the mean transit time (MTT) for 99mTc- 
disofenin obtained scintigraphically showed 
an increasingly prolonged transit of 99mT~- 
disofenin through the liver after warm isch- 
emia and transplantation. Differences ob- 
served between normal and 0.5-hr warm 
ischemia, 0.5- and l.O-hr warm ischemia, 
and l.O-hr warm ischemia and transplanted 
animals were statistically significant (P 
< 0.05) for both the scintigraphic technique 
and the BSP determinations. 
Evaluation of liver biopsy specimens in the 
various experimental groups failed to show 
any reproducible pattern of injury for the 
animals subjected to 0.5 or 1.0 hr of warm 
ischemia. Animals undergoing transplanta- 
tion involving 1 hr of cold storage were 
found to have substantial lobular necrosis, 
vacuolization, and hepatic cord disorganiza- 





Experiment animal Direct Indirect 
1 16.2 14.1 
2 13.7 13.9 
3 16.7 15.1 
4’ 21.6 19.8 
’ Direct simultaneous injections of 99mTc-disofenin 
into portal vein and hepatic artery in a ratio of 2: 1. 
b Indirect refers to the intravenous injection of 99mTc- 
disofenin and subsequent calculation of MTT using de- 
convolution. 
‘This animal suffered a cardiac arrest prior to the 
initiation of this scan. 
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FIG. 3. Sensitivity of quantitative scintigraphy and 
BSP testing to various degrees of hepatic ischemia/re- 
perfusion injury. (Left) MTT determinations were done 
for several different groups; normal (n = 6), animals 
subjected to OS-hr warm &hernia (n = 4) or l.O-hr 
warm ischemia (n = 4), or animals undergoing ortho- 
topic transplantation (n = 6). Statisticaliy significant 
differences were noted between normal and OS-hr warm 
&hernia, 0.5- and I.O-hr warm ischemia, and l.O-hr 
warm ischemia and transplant (P < 0.05 in ah cases). 
(Right) BSP determinations between normal (n = 6) and 
0.5-hr warm &hernia (n = 4), 0.5- and I.O-hr warm 
&hernia (n = 4) and 1 .O-hr warm ischemia and trans- 
plant (n = 6) were all statistically significantly different 
(P < 0.05). 
DISCUSSION 
99mTc-disofenin, a member of the iminodi- 
acetic acid (HIDA) family of tracers, is ac- 
tively taken up by hepatocytes via a mecha- 
nism similar to that involved in bilirubin 
uptake [13-l 51. Previous attempts at mea- 
suring hepatic parenchymal transit were 
hampered by the fact that the liver is contin- 
uously and simultaneously extracting and 
excreting tracer [ 161. This overlap of tracer 
uptake, transit, and excretion has made 
quantitative analysis quite difficult. 
Deconvolutional analysis is a mathemati- 
cal technique which permits “correction” of 
the hepatic time-activity curve for the 
changing blood concentration of tracer being 
presented to the liver. Continuous measure- 
ment of blood concentration of tracer (via 
the heart time-activity curve) allows recov- 
ery of the hepatic time-activity curve that 
would have occurred had the tracer been in- 
jected in the hepatic blood supply as a single 
short bolus without recirculation. This curve 
simulates a “single-pass” exposure of the 
liver to tracer and thus measurement of the 
time required for transit through the liver is 
readily calculated. 
In this paper we validated that the decon- 
volution process used to reconstruct the he- 
patic time-activity curve from data acquired 
after intravenous injection accurately reflects 
the actual hepatic time-activity curve ob- 
tained from direct injection of tracer into the 
afferent blood supply of the liver. The mean 
transit time determined from the decon- 
volved curve and the “actual” curve corre- 
lated closely. The correlation between the 
deconvolved and actual hepatic time-activ- 
ity curves was also found when the experi- 
mental animal had suffered unintended isch- 
emit damage to the liver; both MTT deter- 
minations were similarly prolonged. These 
results are thus similar to our previous work 
in this area where it was shown that the de- 
convolution process accurately recon- 






of hepatic cords 
Normal 
(n = 4) 
0.5 hr of warm &hernia 
(n = 5) 
1 .O hr of warm &hernia 
(n = 4) 
Transplant 
(n = 6) 
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after the intravenous injection of i3’I-ortho- 
iodohippurate when compared to the renal 
time-activity curve obtained after direct in- 
jection of tracer into the renal artery of a 
uninephrectomized animal [6]. The correla- 
tion coefficient in that case was 0.97. The 
technique of deconvolutional analysis ap- 
pears to reliably provide a critical, previously 
missing element in the process required to 
quantitate organ function scintigraphically. 
Using the reconstructed hepatic time-ac- 
tivity curves as a basis for quantitating he- 
patic function, we calculated the mean tran- 
sit time (MTT), the time required in minutes 
for a molecule of bilirubin analog (disofenin) 
to enter and then exit the liver, under a vari- 
ety of experimental conditions. The MTT 
increased progressively after increasing doses 
of ischemia/reperfusion in a pattern that par- 
alleled results of simultaneously performed 
BSP determinations. It is possible that the 
distinction between the normal and i-hr 
ischemic groups could have been made on 
the basis of an effect of the surgical procedure 
itself rather than just ischemia since the nor- 
mals had not undergone an abdominal inci- 
sion with intraabdominal manipulation as 
the $-hr ischemic group had done. However, 
the $hr ischemia, the 1-hr ischemia, and the 
transplant group, all had undergone a similar 
abdominal incision and intraoperative ma- 
nipulation. Thus the significant difference in 
MTT determination among these groups 
could not have been explained on the basis of 
an artifact related to the operative procedure 
itself. Results of MTT testing and BSP deter- 
minations correlated with the histologic eval- 
uation only in that the transplanted group 
showed rather severe injury and this group 
also had the most prolonged MTT determi- 
nations and the most prolonged plasma TI,Z 
for BSP. However, it was not possible to dis- 
tinguish among the other experimental 
groups histologically as was the case with the 
scintigraphic and BSP testing techniques. We 
conclude from these results that the quanti- 
tative imaging with deconvolution is a rela- 
tively sensitive technique capable of identi- 
fying mild degrees of hepatic injury not asso- 
ciated with clear-cut histologic damage and 
that quantitative imaging with 99”Tc-diso- 
fenin is as sensitive a technique as BSP test- 
ing in this regard. 
Although in this experimental study MTT 
determinations and the TIjZ of BSP were sim- 
ilarly prolonged after ischemic injury, in cer- 
tain clinical situations the MTT determina- 
tions give more reliable information about 
hepatocyte function per se. If, for example, 
the clinical situation were one involving se- 
vere splanchnic vasoconstriction, propor- 
tionally less of the cardiac output would 
reach the liver and the liver would have less 
opportunity to extract the test substance 
from the blood, over time. In the case of the 
BSP determination the T1,2 would be pro- 
longed although the liver itself was function- 
ing normally. The quantitative imaging tech- 
nique with deconvolutional analysis would 
automatically take into account increased 
recirculation via the heart time-activity 
curve; the reconstructed hepatic time-activ- 
ity curve would be unaltered; and, assuming 
normal hepatocyte function, the MTT deter- 
mination would be normal. Thus, this quan- 
titative imaging technique is essentially a 
flow-independent measurement of hepato- 
cyte function, a feature which is a potential 
advantage in clinically sorting out problems 
related to hepatocyte injury versus changes 
in blood supply to the liver. 
Quantitative imaging with deconvolution 
has the potential for wide clinical applica- 
tion. The technique is adaptable to the stan- 
dard nuclear medicine minicomputer and 
provides rapid results, and injection of 
99mTc-disofenin is not associated with the 
occasional severe reactions associated with 
BSP administration. An application which 
appeals to us particularly relates to liver 
transplantation. Quantitative scintigraphy 
could be used to evaluate the unstable po- 
tential liver donor or the immediate function 
of a questionable liver transplant in the peri- 
operative period. Further studies, now being 
carried out, will test the application of this 
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